Les laboratoires de recherche et les locaux d'Enzolve Technologies sont situés au Belfield Innovation Park, dans l'enceinte de l'University College Dublin. La société et ses installations de recherche et développement sont certifiées conformes au système qualité ISO 13485/2003 conformément aux directives européennes au sujet du diagnostic in vitro (IVD).
Enzolve Technologies a également accès à un équipement et des installations de pointe au sein du Conway Institute et, grâce à son projet de Innovation Partnership (Partenariat d'Innovation) soutenu par Enterprise Ireland, la société bénéficie de la contribution directe de scientifiques de l'UCD.
Products & Services
Website supported by
Search
Latest News
Newborn
Screening - First Steps into the marketplace
Irish technology to enable metabolic disorder screening among newborns in the developing world and remote locations... Read full article on the web Technology…
Irish technology to enable metabolic disorder screening among newborns in the developing world and remote locations... Read full article on the web Technology…
Screen
your baby’s health
Enzolve Technologies recently launched a novel newborn screening test for Phenylketonuria (PKU), an inherited metabolic disorder that results in severe mental…
Enzolve Technologies recently launched a novel newborn screening test for Phenylketonuria (PKU), an inherited metabolic disorder that results in severe mental…
UCD
campus company to begin production of newborn screening kits
for international markets
Enzolve Technologies has recently secured substantial investment from Enterprise Ireland to allow them to begin immediate production of diagnostic screening kits…
Enzolve Technologies has recently secured substantial investment from Enterprise Ireland to allow them to begin immediate production of diagnostic screening kits…